Novel Microdevices is a medical device startup that develops a handheld point-of-care medical device to facilitate molecular diagnostics.
Novel Microdevices has raised $1.0M in total funding. The most recent round was Convertible Note. The last funding was announced in April 2026.
Novel Microdevices's investors include TEDCO, CARB-X, National Institutes of Health, Maryland Department of Commerce.
Novel Microdevices is headquartered in Baltimore, United States.
Novel Microdevices is a medical device startup that develops a handheld point-of-care medical device to facilitate molecular diagnostics.
Novel Microdevices is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Novel Microdevices — Funding & Investors." VCBacked, April 27, 2026, https://www.vcbacked.co/company/novel-microdevices. Accessed August 17, 2026.
VCBacked. (2026). Novel Microdevices — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/novel-microdevices
{{cite web |title=Novel Microdevices — Funding & Investors |url=https://www.vcbacked.co/company/novel-microdevices |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated